Activity in WDR neurons is established as a core component of the N1 potential, supporting the use of spinal SEPs as a translational biomarker of analgesic target engagement within the dorsal horn of anaesthetised Wistar rats.
Abstract
Identifying objective translational biomarkers of spinal nociceptive processing is important to accelerate analgesic development. The primary negative component (N1) of spinal somatosensory evoked potentials (SEPs) has been proposed as such a biomarker. However, the cellular substrates of the N1 potential (evoked by innocuous electrical stimulation) and their relevance to nociceptive processing have not been directly demonstrated. Here, we employed a 64-channel multielectrode recording approach in the dorsal horn of anaesthetised Wistar rats to functionally characterise the neuronal populations activated during the generation of spinal SEPs and determine how their activity is modulated by tapentadol. Single units were classified based on their responses to mechanical stimulation of the hindpaw, and their electrically evoked responses to sciatic nerve stimulation. Of 59 well-isolated units, 47 (80%) were classified as wide dynamic range (WDR) neurons and 12 (20%) as low-threshold mechanoreceptive (LTMR) neurons, spatially distributed across spinal laminae III-V. Tapentadol (10 mg/kg, intraperitoneal (i.p)) selectively attenuated the mechanically- and electrically-evoked activity of WDR neurons without affecting LTMR responses. This WDR-inhibition was largely reversed by naloxone (0.25 mg/kg, i.p) but not by atipamezole (1 mg/kg, i.p), identifying a predominant opioid receptor-mediated mechanism of inhibition in the naïve state. The magnitude of WDR inhibition by tapentadol correlated with the degree of reduction of the N1 amplitude. These findings establish activity in WDR neurons as a core component of the N1 potential, supporting the use of spinal SEPs as a translational biomarker of analgesic target engagement within the dorsal horn. Summary Multielectrode recordings identify inhibition of WDR neurons as the mechanism by which tapentadol modulates spinal SEPs, supporting use as a biomarker of spinal nociceptive processing.
Objective Spinal evoked compound action potentials (ECAPs) provide a quantitative measure of the neural response during spinal cord stimulation (SCS) and can be leveraged in closed-loop applications to control dose in response to spinal cord movement. However, interpretation of ECAPs recorded in vivo is limited by susceptibility to noise, inter-subject variability, and other confounding factors. As SCS systems evolve and the clinical and research applications of ECAPs expand, it is critical to understand how physiological and technical factors influence ECAP generation and morphology. Approach We used a computational modeling framework to systematically investigate the influence of anatomical (e.g., dorsal cerebrospinal fluid (dCSF) thickness), stimulation (e.g., pulse width, waveform shape, stimulation configuration, stimulation frequency), and recording configurations on the neural responses and ECAPs generated during SCS. We employed a hybrid computational modeling approach, coupling finite element method models with multicompartment axon models to simulate neural responses to SCS. Using these models, we characterized the spatiotemporal dynamics of neural recruitment and the resulting ECAP waveforms. Main results Neural responses and model ECAPs were strongly influenced by factors, such as dCSF thickness, pulse width, and stimulation waveform shape. Stimulation parameters introduced trade-offs between axonal recruitment thresholds, neural activation selectivity, and ECAP timing and morphology. Notably, similar ECAP amplitudes could obscure differences in the underlying neural recruitment. Complex ECAP morphologies also emerged in response to distinct stimulation paradigms, reflecting changes in the spatiotemporal properties of axonal activation. Additionally, we demonstrate that the selection of recording electrodes can be optimized to enhance recorded ECAP amplitudes. Significance Our findings provide a theoretical framework to advance our mechanistic understanding of SCS-induced ECAPs and offer insights into optimization strategies to improve closed-loop SCS therapies.
Meagan K Brucker-Hahn, Hans J. Zander, David A. Dinsmoor et al.· bioRxiv· 0 citations
Deep brain stimulation (DBS) of the ventral intermediate nucleus (Vim) of the thalamus may be used to treat medication refractory essential tremor. Using recordings from in vivo human Vim neurons, our previous work has suggested that evoked potentials (that we termed quasi-evoked inhibition) ∼2 ms following high frequency microstimulation pulses may be related to inhibitory synapses onto the Vim. Here, we investigate whether (i) quasi-evoked inhibition is related to clinical tremor reduction, and (ii) if quasi-evoked inhibition is dependent on the stimulation location within the Vim. By developing an objective determination of the presence or absence of quasi-evoked inhibition and utilizing accelerometer recordings, we showed that recordings with quasi-evoked inhibition at 100 Hz microstimulation exhibit greater tremor reduction than those without (P < 0.05, BF > 30). The number of stimulation pulses with quasi-evoked inhibition is also correlated with tremor reduction (rho = 0.18, P < 0.05) at all stimulation frequencies >=100 Hz. Furthermore, by analyzing microelectrode trajectories reconstructed from structural MRIs, we found that proximity to the ventral caudal border (P < 0.005) and to a previously established sweet spot (P < 0.05) are anti-correlated with the number of stimulation pulses with quasi-evoked inhibition. Our findings suggest that quasi-evoked inhibition is a potential biomarker of tremor reduction by means of network inhibition, and the more posterior regions of the Vim may allow for better recruitment of inhibition. This may be useful for closed-loop stimulation design.
Zoe Paraskevopoulos, D. Crompton, Sarah Iskin et al.· bioRxiv· 0 citations
This work demonstrates for the first time in humans that clinical-grade lumbosacral epidural paddle arrays capture sufficient fine-scale spatiotemporal structure to decode these overlapping inputs from highly overlapping, volume-conducted epidural fields.
Alexander G. Steele, M. Candela, Gracie Hufft et al.· Research Square· 0 citations
Spinal cord stimulation (SCS) is a widely used neuromodulatory therapy for chronic neuropathic pain, yet the cellular and molecular mechanisms underlying its clinical efficacy remain incompletely understood. This review synthesizes current literature on the neurophysiology of pain transmission and the mechanistic basis of major SCS paradigms (tonic, high-frequency, burst, and closed-loop stimulation), highlighting how each modality engages distinct dorsal horn circuits, glial and inflammatory pathways, as well as supraspinal networks involved in the affective dimension of pain. Particular attention is given to the evoked compound action potential (ECAP) as an emerging electrophysiological biomarker that enables real-time, feedback-guided stimulation and offers insight into the biophysical determinants of dorsal column activation. We also examine preclinical and clinical evidence linking SCS to modulation of central sensitization, neuroinflammatory signaling, and autonomic regulation, while identifying persistent gaps in mechanistic understanding. Finally, we discuss future directions, including AI-assisted, personalized SCS programming and expanding indications beyond classical neuropathic pain, underscoring the need for multimodal experimental approaches to more precisely define how SCS achieves analgesia.
Milan Patel, Alison J Deng, Ameya V Belamkar et al.· International Journal of Mol...· 0 citations
Chronic pain is associated with maladaptive plasticity within nociceptive circuits of the spinal dorsal horn (SDH). However, whether this reorganization selectively targets specific neuronal populations remains unresolved. Addressing this question has been technically challenging because reliable measurements of somatic excitability in spinal neurons are difficult to obtain under experimental pain conditions, where tissue integrity and recording stability are frequently compromised. In this comparative study, we examined neuronal excitability in two electrophysiologically distinct lamina II populations; tonic and initial burst (IB) firing neurons, under basal conditions and across three chronic pain models: complete Freund's adjuvant (CFA), spinal nerve ligation (SNL), and streptozotocin (STZ). Our results demonstrate that chronic pain induces firing pattern-dependent adaptations in intrinsic excitability, with selective enhancement of responsiveness in IB neurons. This interpretation is reinforced by principal component analysis (PCA), which partitions IB and tonic neurons into distinct electrophysiological domains. This subtype-specific plasticity may contribute to persistent amplification of nociceptive signaling by reshaping microcircuit dynamics within the superficial dorsal horn, thereby facilitating pathological nociceptive transmission during established pain states.